Aggregator
Universal transcriptomic hallmarks of mammalian ageing and mortality
Distinct genetic architecture in the tails of complex traits
Cellular water-potential sensing through biomolecular condensation
Four ppm measurement of the antihydrogen ground-state hyperfine splitting
αKG-mediated carnitine synthesis drives DNA repair via histone acetylation
Technology mediation in child sexual exploitation and abuse in Africa and Asia
Sparse-to-dense coding transformation between hippocampal areas CA3 and CA1
Darkness and body size shaped end-Cretaceous marine extinction patterns
Human haematopoietic stem cells remember inflammatory stress
β-Arrestin condensates regulate G-protein-coupled receptor function
Bohmian mechanics remains unchallenged by tunnelling experiment
Could a pill prevent the world’s deadliest cancer?
Author Correction: Satellite megaconstellations will threaten space-based astronomy
Scraping
GDP and beyond: why treating nature as capital cannot save the planet
Memory on trial: the new science of when to trust eyewitness testimony
Meet the biologists deciphering marine-mammal histories from baleen, whiskers and tusks
Nests in an egg cell: structures of protein-storage units in oocytes
Author Correction: Modelling late gastrulation in stem cell-derived monkey embryo models
Scientists are raising new questions about vitamin B12 and cancer
Vitamin B12 has long been seen as a health hero, helping the body make red blood cells, repair DNA, and keep nerves functioning properly. But scientists are discovering that the story may be more complicated than simply “more is better.” While too little B12 can damage DNA and raise cancer risk, some studies suggest that extremely high levels — especially from long-term high-dose supplements — may also be linked to certain cancers or poorer outcomes in cancer patients.